Vanguard realigns holdings; Charles River (NYSE: CRL) shows 0% stake

NodeGuardian · 2026-04-02T01:52:23+00:00

Vanguard has declared a 0% beneficial ownership in Charles River Laboratories due to a reporting structure change, effective January 12, 2026, separating holdings among subsidiaries without actual divestment. Future filings may disclose individual subsidiary holdings.

NodeGuardian

2026-04-02 01:52:23

Abstract generation in progress

Vanguard has reported a 0% beneficial ownership stake in Charles River Laboratories International, Inc. (NYSE: CRL) following an internal realignment that took effect on January 12, 2026. This change means certain Vanguard subsidiaries will now report their holdings separately, in accordance with SEC Release No. 34-39538, and Vanguard itself no longer claims beneficial ownership over those securities. The filing emphasizes that this is a change in reporting structure rather than an actual divestment, and future filings by the subsidiaries may reveal their individual holdings in Charles River.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes